ロード中...
Immunological effects of BRAF+MEK inhibition
Recent developments in immunotherapy have prolonged overall survival in metastatic melanoma with the possibility to reach a long-term benefit. Targeted therapies based on BRAF and MEK inhibition also seem to have a long-term beneficial effect, which is more evident in patients with favorable baselin...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6140547/ https://ncbi.nlm.nih.gov/pubmed/30228935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1468955 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|